Loraine Kay D Cabral

8PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer diagnosisEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 12, 2025
Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells.

Loraine Kay Cabral, Cyrollah Disoma, Paola Tarchi

|Sep 09, 2023
PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma.

Caecilia Sukowati, Loraine Kay D Cabral, Beatrice Anfuso

|Feb 25, 2023
Network Analysis for the Discovery of Common Oncogenic Biomarkers in Liver Cancer Experimental Models.

Loraine Kay D Cabral, Pablo J Giraudi, Gianluigi Giannelli

|Jun 10, 2022
Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals.

Loraine Kay D Cabral, Luca Grisetti, Muhammad Yogi Pratama

|Oct 23, 2021
The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma.

Loraine Kay D Cabral, Peter Andrew C Reyes, Lory S Crocè

|Jan 22, 2021
Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma.

Caecilia H C Sukowati, Loraine Kay D Cabral, Claudio Tiribelli

Pageof 2

Frequent Collaborators

8 joint publications

Claudio Tiribelli

6 joint publications

Caecilia Sukowati

2 joint publications

Lory S Crocè

2 joint publications

Devis Pascut